Nothing Special   »   [go: up one dir, main page]

NO973533D0 - Kombinasjonsterapi mot HIV infeksjon ved anvendelse av proteaseinhibitoren indinavir og revers-transskriptaseinhibitoren 3TC, eventuelt sammen med AZT, DDI eller DDC - Google Patents

Kombinasjonsterapi mot HIV infeksjon ved anvendelse av proteaseinhibitoren indinavir og revers-transskriptaseinhibitoren 3TC, eventuelt sammen med AZT, DDI eller DDC

Info

Publication number
NO973533D0
NO973533D0 NO973533A NO973533A NO973533D0 NO 973533 D0 NO973533 D0 NO 973533D0 NO 973533 A NO973533 A NO 973533A NO 973533 A NO973533 A NO 973533A NO 973533 D0 NO973533 D0 NO 973533D0
Authority
NO
Norway
Prior art keywords
ddi
azt
ddc
optionally
reverse transcriptase
Prior art date
Application number
NO973533A
Other languages
English (en)
Other versions
NO973533L (no
NO314568B1 (no
Inventor
Jeffrey A Chodakewitz
Emilio A Emini
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO973533D0 publication Critical patent/NO973533D0/no
Publication of NO973533L publication Critical patent/NO973533L/no
Publication of NO314568B1 publication Critical patent/NO314568B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO19973533A 1995-02-01 1997-07-31 Kombinasjon mot HIV-infeksjon ved anvendelse av HIV-protease- inhibitoren indinavir og reverstranskriptaseinhibitoren 3TC sammen med AZT NO314568B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/382,113 US6689761B1 (en) 1995-02-01 1995-02-01 Combination therapy for HIV infection
PCT/US1996/001417 WO1996023509A1 (en) 1995-02-01 1996-01-29 Combination therapy for hiv infection using the hiv protease inhibitor indinavir and the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc

Publications (3)

Publication Number Publication Date
NO973533D0 true NO973533D0 (no) 1997-07-31
NO973533L NO973533L (no) 1997-10-01
NO314568B1 NO314568B1 (no) 2003-04-14

Family

ID=23507574

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19973533A NO314568B1 (no) 1995-02-01 1997-07-31 Kombinasjon mot HIV-infeksjon ved anvendelse av HIV-protease- inhibitoren indinavir og reverstranskriptaseinhibitoren 3TC sammen med AZT

Country Status (38)

Country Link
US (1) US6689761B1 (no)
EP (1) EP0806957B1 (no)
JP (1) JPH10513186A (no)
KR (1) KR19980701856A (no)
CN (1) CN1160081C (no)
AR (1) AR002957A1 (no)
AT (1) ATE243519T1 (no)
AU (1) AU711176B2 (no)
BR (1) BR9607714A (no)
CA (1) CA2211973A1 (no)
CO (1) CO4700430A1 (no)
CZ (1) CZ244497A3 (no)
DE (1) DE69628819T2 (no)
DK (1) DK0806957T3 (no)
DZ (1) DZ1988A1 (no)
EA (1) EA000437B1 (no)
EE (1) EE03514B1 (no)
ES (1) ES2200052T3 (no)
FI (1) FI973184A (no)
HK (1) HK1004659A1 (no)
HR (1) HRP960045B1 (no)
HU (1) HUP9800810A3 (no)
IL (1) IL116925A (no)
IS (1) IS1970B (no)
MX (1) MX9705916A (no)
MY (1) MY121604A (no)
NO (1) NO314568B1 (no)
NZ (1) NZ302153A (no)
PE (1) PE38397A1 (no)
PL (1) PL182742B1 (no)
PT (1) PT806957E (no)
SA (1) SA96160669B1 (no)
SK (1) SK103797A3 (no)
TR (1) TR199700735T1 (no)
TW (1) TW442291B (no)
WO (1) WO1996023509A1 (no)
YU (1) YU49417B (no)
ZA (1) ZA96722B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998008539A1 (en) * 1996-08-26 1998-03-05 Chiron Corporation Postinfection human immunodeficiency virus (hiv) vaccination therapy
AU6761198A (en) * 1998-03-17 1999-10-11 Julianna Lisziwiewicz Anti-hiv combination comprising hydroxyurea, ddi, and a protease inhibitor
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
CA2374198A1 (en) * 1998-05-29 1999-12-02 Maki Arai Combination therapy for treatment of fiv infection
JP2003523721A (ja) 1998-12-31 2003-08-12 カイロン コーポレイション 抗原性hivc型ポリペプチドをコードするポリヌクレオチド、ポリペプチド、およびそれらの使用
JP5033303B2 (ja) 2001-07-05 2012-09-26 ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド 抗原性c型hivポリペプチドをコードするポリヌクレオチド、ポリペプチドおよびそれらの使用
CA2583195A1 (en) * 2004-11-19 2006-05-26 Boehringer Ingelheim International Gmbh Method for treating hiv infection through co-administration of tipranavir and reverset
AU2006274455B2 (en) * 2005-07-27 2011-06-09 Emil Toma Zalcitabine (DDC) boosted lamivudine (3TC) compositions for antiretroviral therapy
WO2018128993A1 (en) * 2017-01-04 2018-07-12 Oyagen, Inc. Compounds, compositions, and methods for treating human immunodeficiency virus

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US5254539A (en) * 1985-08-26 1993-10-19 U.S. Government, Dept. Of Health And Human Services, C/O National Institutes Of Health Method of treating HIV with 2',3'-dideoxyinosine
US5028595A (en) * 1987-09-18 1991-07-02 Hoffmann-La Roche Inc. Method for preventing AIDS in a subject or treating a subject infected with the AIDS virus
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
IL100502A (en) 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
US5413999A (en) * 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
KR100311551B1 (ko) 1993-03-31 2001-12-28 폴락 돈나 엘. Aids 치료용 약제학적 배합물 중의 hiv 프로테아제 억제제
IL114208A0 (en) 1994-06-27 1995-10-31 Merck & Co Inc Combinations of compounds pharmaceutical compositions containing them and their use as hiv protease inhibitors

Also Published As

Publication number Publication date
ZA96722B (en) 1996-08-26
KR19980701856A (ko) 1998-06-25
US6689761B1 (en) 2004-02-10
NO973533L (no) 1997-10-01
PL321660A1 (en) 1997-12-22
SA96160669B1 (ar) 2006-07-30
CO4700430A1 (es) 1998-12-29
ES2200052T3 (es) 2004-03-01
IL116925A (en) 2000-07-26
CZ244497A3 (cs) 1998-01-14
HK1004659A1 (en) 1998-12-04
IS1970B (is) 2004-12-15
CN1179722A (zh) 1998-04-22
IS4533A (is) 1997-07-29
NO314568B1 (no) 2003-04-14
EP0806957B1 (en) 2003-06-25
DZ1988A1 (fr) 2002-07-20
AR002957A1 (es) 1998-05-27
AU711176B2 (en) 1999-10-07
BR9607714A (pt) 1998-01-13
CN1160081C (zh) 2004-08-04
SK103797A3 (en) 1998-02-04
DK0806957T3 (da) 2003-09-29
EA000437B1 (ru) 1999-08-26
NZ302153A (en) 1998-12-23
EE03514B1 (et) 2001-10-15
AU4774896A (en) 1996-08-21
HUP9800810A3 (en) 2001-05-28
YU49417B (sh) 2006-01-16
DE69628819T2 (de) 2004-05-13
YU6396A (sh) 1999-06-15
EE9700165A (et) 1998-02-16
WO1996023509A1 (en) 1996-08-08
EA199700150A1 (ru) 1997-12-30
HRP960045B1 (en) 2004-06-30
PT806957E (pt) 2003-10-31
EP0806957A1 (en) 1997-11-19
FI973184A0 (fi) 1997-07-31
HRP960045A2 (en) 1997-10-31
JPH10513186A (ja) 1998-12-15
TW442291B (en) 2001-06-23
MY121604A (en) 2006-02-28
MX9705916A (es) 1997-10-31
ATE243519T1 (de) 2003-07-15
PL182742B1 (pl) 2002-02-28
IL116925A0 (en) 1996-05-14
HUP9800810A2 (hu) 1998-07-28
PE38397A1 (es) 1997-10-09
DE69628819D1 (de) 2003-07-31
TR199700735T1 (xx) 1998-02-21
CA2211973A1 (en) 1996-08-08
FI973184A (fi) 1997-09-30

Similar Documents

Publication Publication Date Title
NO982556L (no) Behandling av CNS-virkningene av HIV med VX-478, alene eller i kombinasjon med AZT eller 3TC
DE69408939D1 (de) Keramischer Verbundwerkstoff
NO904737D0 (no) Orientert varmeforseglbar flersjiktsstruktur, samt fremgangsmaate for fremstilling av en slik struktur.
FI953954A0 (fi) HIV:n käänteistranskriptaasin inhibiittoreita
DE68920160D1 (de) Klebstoffmischungen und Laminate.
NO973533D0 (no) Kombinasjonsterapi mot HIV infeksjon ved anvendelse av proteaseinhibitoren indinavir og revers-transskriptaseinhibitoren 3TC, eventuelt sammen med AZT, DDI eller DDC
DK0754291T3 (da) Hjælperedskab til anvendelse ved navigation, positionsbestemmelse og/eller orientering
FI933907A0 (fi) Refraktometri
DE3886155D1 (de) Anthracyclin-Derivate mit Inhibitorwirkung gegen die reverse Transkriptase des menschlichen Immundefizienzvirus.
FR2713463B1 (fr) Couteau à éplucher les ananas.
KR950011761U (ko) 천정의 주, 보조 간받이 연결구
NO953778D0 (no) Enhet for anbringelse av små flasker, ampuller og lignende
DE68903039D1 (de) Schuettgutverlader fuer haefen und dgl.
ES1031988Y (es) Derspertador y antirronquido por vibracion en la muñeca.
NO922986L (no) Varmeoverfoerbart laminat og klebemiddel for dette, samt fremgangsmaate for fremstilling av laminatet
ATA265189A (de) Steighilfe fuer rollstuehle o.dgl.
FI920386A (fi) Ovenpainike tai vastaava
NO903856D0 (no) Emulgeringsmiddel, invertemulsjoner fremstilt ved hjelp av dette, og anvendelse av invertemulsjonene i borehull.
IT1269867B (it) Impiego di cisteamina come prodotto antiretrovirale
FI1268U1 (fi) Anordning foer att omvandla en roddbaot eller motsvarande till en segelbaot
FR2712499B1 (fr) Ensemble laser-sonde endoscopique utile en microchirurgie.
SE9601942L (sv) Bygganordning
ES1031332Y (es) Empuñadura para bastones y similares.
ES1031052Y (es) Lavamanos activado por infrarrojos.
KR950031759U (ko) 피. 시. 비 기판 고정장치

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees